Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Short Daily Hemodialysis vs. Short Daily Hemofiltration (Search for Optimal Prescription)

Identifieur interne : 002801 ( Main/Exploration ); précédent : 002800; suivant : 002802

Short Daily Hemodialysis vs. Short Daily Hemofiltration (Search for Optimal Prescription)

Auteurs : R. Galland ; J. Traeger ; B. Béné [France] ; E. Delawari

Source :

RBID : ISTEX:98AFA4D1466381B511EBC0EE701815BC07A40529

Abstract

It has been shown that daily hemodialysis as well as convective transfer by hemofilitration improve the quality of extra renal treatment. Two following phases of treatment of three weeks each were tested in 2 patients: daily hemodialysis 2.5 h 6 times/week (HD*6) and daily hemofiltration 2.75 h 6 times/week (HF*6) performed according to the following modalities. Phase I, blood flow rates (QB): 300 mL/min, hemofilter 1.4 m2AN 69 dialysate flow 500 mL/min. Phase II, QB: 150 mL/min, hemofilter 1m2AN 69, exchange volume of 10 L/session; 5 L predilution and 5 L postdilution (conditions were limited by the device). We measured, during the third week of treatment of each phase, the weekly mass transfers and the predialysis plasma levels of urea (U), creatinine (C), phosphate (P), and B2 microglobulin (B2M). In the 2 phases, HD*6 and HF*6, respectively, the weekly urea Kt was: 120 vs. 60 L; std Kt/V: 3.30 vs. 2.0; npcr: 1.26 vs. 1.42 g kg–1 day–1. Mass transfer/week Predialytic levels/L HD*6 HF*6 HD*6 HF*6 U (mmol)  2366  2204  23.2  38.5 C (µmol) 67240 51096 769.5 934.8 P (mmol)   127   111.5   1.91   2.34 B2M (mg)   311   763.5  34.2  30.16 In HF*6, predialysis solute concentration increased and weekly small molecule mass transfer was insufficient. B2M mass transfer was significantly increased and predialytic plasma concentration decreased, showing a higher clearance of middle molecules with convective transfer. The clinical tolerance was excellent during the two phases of treatment. This study allows to determine the optimal conditions for adequate daily HF: higher QB and exchange volume. Further studies with QB of at least 300 mL/min and with exchange volume of 15 L/session seem to be necessary.

Url:
DOI: 10.1111/j.1492-7535.2004.0085s.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Short Daily Hemodialysis vs. Short Daily Hemofiltration (Search for Optimal Prescription)</title>
<author>
<name sortKey="Galland, R" sort="Galland, R" uniqKey="Galland R" first="R." last="Galland">R. Galland</name>
</author>
<author>
<name sortKey="Traeger, J" sort="Traeger, J" uniqKey="Traeger J" first="J." last="Traeger">J. Traeger</name>
</author>
<author>
<name sortKey="Bene, B" sort="Bene, B" uniqKey="Bene B" first="B." last="Béné">B. Béné</name>
</author>
<author>
<name sortKey="Delawari, E" sort="Delawari, E" uniqKey="Delawari E" first="E." last="Delawari">E. Delawari</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:98AFA4D1466381B511EBC0EE701815BC07A40529</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1492-7535.2004.0085s.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-6WXFQ7SP-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000892</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000892</idno>
<idno type="wicri:Area/Istex/Curation">000886</idno>
<idno type="wicri:Area/Istex/Checkpoint">001273</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001273</idno>
<idno type="wicri:doubleKey">1492-7535:2004:Galland R:short:daily:hemodialysis</idno>
<idno type="wicri:Area/Main/Merge">002810</idno>
<idno type="wicri:Area/Main/Curation">002801</idno>
<idno type="wicri:Area/Main/Exploration">002801</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Short Daily Hemodialysis vs. Short Daily Hemofiltration (Search for Optimal Prescription)</title>
<author>
<name sortKey="Galland, R" sort="Galland, R" uniqKey="Galland R" first="R." last="Galland">R. Galland</name>
<affiliation>
<wicri:noCountry code="no comma">AURAL</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Traeger, J" sort="Traeger, J" uniqKey="Traeger J" first="J." last="Traeger">J. Traeger</name>
<affiliation>
<wicri:noCountry code="no comma">AURAL</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bene, B" sort="Bene, B" uniqKey="Bene B" first="B." last="Béné">B. Béné</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Hospal R&D, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Delawari, E" sort="Delawari, E" uniqKey="Delawari E" first="E." last="Delawari">E. Delawari</name>
<affiliation>
<wicri:noCountry code="no comma">AURAL</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Hemodialysis International</title>
<title level="j" type="alt">HEMODIALYSIS INTERNATIONAL</title>
<idno type="ISSN">1492-7535</idno>
<idno type="eISSN">1542-4758</idno>
<imprint>
<biblScope unit="vol">8</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="85">85</biblScope>
<biblScope unit="page" to="86">86</biblScope>
<biblScope unit="page-count">100</biblScope>
<publisher>Blackwell Science Inc</publisher>
<pubPlace>Oxford, UK; Malden, USA</pubPlace>
<date type="published" when="2004-01">2004-01</date>
</imprint>
<idno type="ISSN">1492-7535</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1492-7535</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">It has been shown that daily hemodialysis as well as convective transfer by hemofilitration improve the quality of extra renal treatment. Two following phases of treatment of three weeks each were tested in 2 patients: daily hemodialysis 2.5 h 6 times/week (HD*6) and daily hemofiltration 2.75 h 6 times/week (HF*6) performed according to the following modalities. Phase I, blood flow rates (QB): 300 mL/min, hemofilter 1.4 m2AN 69 dialysate flow 500 mL/min. Phase II, QB: 150 mL/min, hemofilter 1m2AN 69, exchange volume of 10 L/session; 5 L predilution and 5 L postdilution (conditions were limited by the device). We measured, during the third week of treatment of each phase, the weekly mass transfers and the predialysis plasma levels of urea (U), creatinine (C), phosphate (P), and B2 microglobulin (B2M). In the 2 phases, HD*6 and HF*6, respectively, the weekly urea Kt was: 120 vs. 60 L; std Kt/V: 3.30 vs. 2.0; npcr: 1.26 vs. 1.42 g kg–1 day–1. Mass transfer/week Predialytic levels/L HD*6 HF*6 HD*6 HF*6 U (mmol)  2366  2204  23.2  38.5 C (µmol) 67240 51096 769.5 934.8 P (mmol)   127   111.5   1.91   2.34 B2M (mg)   311   763.5  34.2  30.16 In HF*6, predialysis solute concentration increased and weekly small molecule mass transfer was insufficient. B2M mass transfer was significantly increased and predialytic plasma concentration decreased, showing a higher clearance of middle molecules with convective transfer. The clinical tolerance was excellent during the two phases of treatment. This study allows to determine the optimal conditions for adequate daily HF: higher QB and exchange volume. Further studies with QB of at least 300 mL/min and with exchange volume of 15 L/session seem to be necessary.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement>
<li>Lyon</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Delawari, E" sort="Delawari, E" uniqKey="Delawari E" first="E." last="Delawari">E. Delawari</name>
<name sortKey="Galland, R" sort="Galland, R" uniqKey="Galland R" first="R." last="Galland">R. Galland</name>
<name sortKey="Traeger, J" sort="Traeger, J" uniqKey="Traeger J" first="J." last="Traeger">J. Traeger</name>
</noCountry>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Bene, B" sort="Bene, B" uniqKey="Bene B" first="B." last="Béné">B. Béné</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002801 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002801 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:98AFA4D1466381B511EBC0EE701815BC07A40529
   |texte=   Short Daily Hemodialysis vs. Short Daily Hemofiltration (Search for Optimal Prescription)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021